Seeds For Irradiation - ANVISA Registration 80047300576
Access comprehensive regulatory information for Seeds For Irradiation in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80047300576 and manufactured by manufacturer not specified. The registration is held by MEDSTAR IMPORTAÇÃO E EXPORTAÇÃO LTDA with validity until Jan 15, 2036.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including BOSTON SCIENTIFIC CORPORATION - MARLBOROUGH, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80047300576
25351464067201503
03580620000135
Company Information
Dates and Status
Jan 15, 2016
15/01/2036
09/18/2025 19:00:01
Radioactive Seed System for Therapy
FONTES RADIOTIVAS DE IRÍDIO
Not specified
10405410023
Feb 10, 2014
Radioactive Seed System for Therapy
FONTES RADIOTIVAS DE IRÍDIO
VARIAN MEDICAL SYSTEMS, INC.
10405410023
Feb 10, 2014
Radioactive Seed System for Therapy
FONTES RADIOATIVAS
Not specified
80569320029
Apr 29, 2019
Radioactive Seed System for Therapy
FONTES RADIOATIVAS
NUCLETRON B.V.
80569320029
Apr 29, 2019
Radioactive Seed System for Therapy
Fonte de Cobaldo - Co-60
ECKERT & ZIEGLER BEBIG GMBH
80012590225
May 20, 2019
Sementes Para Irradiacao
TheraSphere Sistema de Microesferas de Vidro Yttrium-90
BOSTON SCIENTIFIC CORPORATION - MARLBOROUGH
10341351042
Nov 11, 2024
Sementes Para Irradiacao
TheraSphere Sistema de Microesferas de Vidro Yttrium-90
Not specified
10341351042
Nov 11, 2024